CMS Clarifies CLIA Certification Requirements for Remote Cytology

CMS Clarifies CLIA Certification Requirements for Remote Cytology

The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.

The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.

Source:

https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2

Senate HELP Committee Votes to Advance Price Transparency Legislation

Senate HELP Committee Votes to Advance Price Transparency Legislation

On July 22, the Senate Health, Education, Labor, and Pensions (HELP) Committee voted to advance the Patients Deserve Price Tags Act (S.2355) by a...

Read More
The Rise of CLIA-Related Rejections: What Labs Should Review

The Rise of CLIA-Related Rejections: What Labs Should Review

Since CMS transitioned CLIA certification to a paperless system in March, TELCOR has noticed an increase in CLIA-related rejections and denials from...

Read More
TELCOR to Debut New QML® Operator Management Capabilities at ADLM 2026

TELCOR to Debut New QML® Operator Management Capabilities at ADLM 2026

LINCOLN, Neb. - June 12, 2026 - TELCOR, the market leader in point of care middleware and the choice of 58% of U.S. hospitals, today announced two...

Read More